返回排名列表

Waystar Holding Corp. (WAY)

被高估
HealthcareHealth Information ServicesUnited States

基本面

61

价格

$25.23

市值

$4.86B

第一部分 · 这家公司值多少

概览

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

资产负债表与流动性

营收

$1.21B

最近12个月(截至2026/6/30)

净利润

$135M

最近12个月(截至2026/6/30)

自由现金流

$283M

股东权益合计

$3.88B

负债合计

$1.91B

流动比率

1.85

利息覆盖率

-

债务/EBITDA

3.80

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形被高估

公允价值

$20.23

当前价格

$25.23

安全边际

-24.7%

公允价值区间

$13.15 - $27.31

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:$33.68
现金流折现法(DCF):$19.62
市盈率法(P/E):$9.72
格雷厄姆成长公式:$11.23
盈利能力价值(EPV):$8.78
合理市净率(P/B):$2.15
股息折现模型(戈登模型):数据不足,无法计算
P/FFO(运营资金):$21.08
周期中段收益:数据不足,无法计算
市销率法(P/S):$24.42
分析师共识:强力买入 (26B / 2H / 0S)
最近财报超预期:+7.42%

估值指标

市盈率(P/E)

36.20

ROE

2.9%

市净率(P/B)

1.22

P/FCF

19.73

毛利率

-

ROIC

3.9%

盈利能力雷达图

价值创造(经济护城河)

ROIC

3.9%

WACC

9.7%

ROIC − WACC

-5.9 pp

ROIC 低于资本成本:公司每投入一美元都在毁灭价值。

基本面分析标准

通过(14)

  • EPS shows upward trend
  • P/FCF 19.73
  • P/B Ratio 1.22
  • Debt/Equity ratio
  • Operating Margin 22.9%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Analyst Consensus 93% Buy
  • Earnings Surprise avg 2.5%
  • Earnings Quality (OCF/NI) 2.17
  • Net Margin Trend 11.2% vs 8.5%

未通过(8)

  • Price CAGR -17.87%
  • ROIC 3.9%
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • ROE 3.6%
  • Share Dilution 24.9%
  • Piotroski F-Score 4/9

不可用(5)

  • Gross Margin NaN%
  • Dividend Payout NaN%
  • Interest Coverage
  • Revenue Growth 5Y (Finnhub)
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-评分

4/9

信号混杂:部分领域需关注

score
criteria

盈利质量

2.17

高质量:盈利有现金流支撑

股权稀释

24.9%

正在发行新股,稀释所有权

机构持股

公司治理

管理团队

姓名职位年龄
Mr. Matthew J. HawkinsCEO & Director53
Mr. Steven M. Oreskovich CPAAdvisor53
Mr. T. Craig BridgeChief Transformation Officer52
Ms. Alpana Wegner CPAChief Financial Officer52
Mr. Amit KhannaChief Product & Technology Officer-
Mr. Anthony CarrozzellaChief Growth Officer of Health Systems & Hospitals-
Mr. Eric AverySenior VP of Business Operations & Intelligence-
Mr. Dustin HamiltonSenior Vice President of Product Management-
Mr. Perry SweetExecutive Vice President of Enterprise Client Experience-
Ms. Amy BishopSenior Vice President of Performance Marketing-

审计风险

1

董事会风险

6

薪酬风险

4

股东权利风险

8

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-02-17

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-07-29

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-07-29

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for WAY, sourced from Markets Gazette.

  • 3/15/2026POSITIVE
    Waystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter

    Despite a 32% stock decline over the past year, Waystar Holding Corp. has attracted significant investor interest, with one fund acquiring $11.5 million worth of shares in the last quarter. Waystar, a provider of cloud-based software for healthcare payment and revenue cycle management, appears to be viewed as undervalued by this particular investor. This substantial purchase, against a backdrop of recent poor stock performance, suggests a contrarian bet on the company's long-term prospects and its position within the healthcare technology sector.

via Markets Gazette